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http://dx.doi.org/10.1016/j.kjms.201Abstract We investigated the prevalence and correlated factors of human immunodeficiency
virus (HIV) among heroin users attending methadone maintenance treatment (MMT) programs
in Central Taiwan, and explored the degree of risk perception of HIV infection among the par-
ticipants. Our study participants were 781 heroin users seeking treatment at the MMT program
at Tsaotun Psychiatric Center in Taiwan. The presence of HIV antibodies was identified by
microparticle enzyme immunoassay and confirmed by western blot. Multivariate logistic
regression was used to identify the independent correlates of HIV infection. The mean age
of the sample was 36.1 years [standard deviation (SD)Z 7.6]; of the patients, 710 (90.9%) were
men. The prevalence of HIV infection among our study population was 20.7%. Multivariate lo-
gistic regression analysis revealed that HIV infection was independently associated with the
age of the patients of initial heroin use, heroin injection use, nondrug-related criminal convic-
tions, needle-sharing behaviors, and sharing injection paraphernalia. A strong agreement ex-
isted between self-reported HIV serostatus and the results of laboratory analyses, with
88.8% of patients reporting their condition correctly. We found a high rate of HIV infection
among patients in the MMT program. Factors associated with HIV infection were mostly relatedt of Public Health, Kaohsiung Medical University, No. 100, Shih-Chuan 1st Road, Sanmin District,
tw (C.T.C. Lee).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
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674 T.-Y. Lin et al.to drug-use behaviors. These findings stress the importance of education regarding drug-risk
behaviors.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Human immunodeficiency virus (HIV) infection is the most
serious global health problem of the 20th century. The
estimated number of adults and children newly infected
with HIV in 2008 was 2.7 million. In the same year, 2 million
AIDS-related deaths were reported [1]. Compared with
European countries, certain Asian countries have signifi-
cantly higher HIV seroprevalence rates [2]. Approximately
4.7 million people are estimated to have HIV infection in
Asia [1], 75% of whom are from China, India, and Thailand
[3].
Compared with the global adult HIV prevalence rate of
0.8% in 2008 [1], the prevalence rate is relatively low in
Taiwan (0.082% in 2009) [4]. Most of the HIV-infected in-
dividuals in Taiwan are men, aged 20e49 years [4]. Prior to
2003, less than 2% of the newly diagnosed cases each year
were injecting drug users (IDUs) [5]. However, in 2006, 60%
(nZ 1778) of the newly diagnosed patients contracted HIV
through intravenous drug use [6]. Injection drug use has
become the main risk factor of HIV infection in the country,
with more than one-third (38%) of IDUs in Taiwan becoming
HIV/AIDS patients [7].
Heroin is the most commonly injected illicit drug in
Taiwan [7]. According to the National Bureau of Controlled
Drugs, in 2008, 52,708 people were incarcerated because of
drug-related crimes, 77% of them being heroin users [8].
Half of the drug users in Taiwan have injected heroin at
least once [9].
Heroin injection is strongly associated with the rapidly
developing HIV epidemic [10] and is specifically associated
with the sharing of injection paraphernalia [7,11]. The
prevalence of HIV is significantly higher among intravenous
heroin users than among noninjection heroin users [12]. A
study conducted in Spain found that approximately one-
third of heroin injectors were HIV positive [13]. Although
injecting drug use is strongly associated with the HIV
epidemic in most Asian countries, including China,
Indonesia, Thailand, and Hong Kong [1], each country has a
different set of independent risk factors. In Hong Kong,
older men were more likely to be involved in HIV-related
risk behaviors [14]. Indonesia, where more than half of
IDUs (52%) had contracted HIV, was the only country in Asia
that females had a higher HIV prevalence rate than male
injectors [1].
Other studies have shown that the main risk factors for
HIV infection also include young age [11], male sex [15],
lower education [16], sex behaviors [17], criminal convic-
tions [18], incarceration [19], depression [20], social sup-
port [20], impulsivity, and severity of dependence [21].
Understanding risk perceptions is important for
designing appropriate strategies for HIV/AIDS prevention
because people’s behavior is guided more by the perceivedrisk of infection than by their actual, but unknown, HIV
status [22]. In Taiwan, the degree of risk perception con-
cerning HIV infection among heroin users is rarely reported
or remains unreported, although the scale of HIV infection
is low in this population.
Studies on HIV infection among heroin users in Taiwan
included incarcerated injection heroin users [7,23]; how-
ever, studies investigating the prevalence of HIV infection
and its related factors among opiate-dependent patients in
methadone maintenance treatment (MMT) programs are
rare. Our study investigates the prevalence and correlates
of HIV infection among heroin users seeking treatment in
the Taiwanese MMT program and explores the degree of
participant risk perception.
Materials and methods
Participants and procedure
Participants in our study were heroin-dependent patients,
aged 18 years, recruited from 2006 to 2010 at an MMT
program at Tsaotun Psychiatric Center in Nantou County,
Central Taiwan. Nantou City comprises approximately
540,000 inhabitants. All attendees were interviewed by a
senior psychiatrist to confirm the heroin-dependence
diagnosis according to the Diagnostic and Statistical
Manual of Mental Disorders-Fourth Edition (DSM-IV) criteria.
They also completed a set of self-reported questionnaires
administered by a trained psychiatric nurse on the first day
of the MMT program. Exclusion criteria included illiteracy
and a diagnosis of mental retardation. The assessment
included demographic data, history of heroin substance
abuse and other substance use, criminal history, and psy-
chosocial information prior to MMT.
Measurements
The heroin-related behaviors of patients were assessed
prior to MMT. Questions included participant ages for initial
substance use and first heroin use, frequency of heroin
detoxification for more than 2 weeks (lifetime), number of
criminal convictions (substance related and nonsubstance
related), main method of heroin administration (injection
or smoking, lifetime), sharing needles with others (yes/no,
lifetime), and sharing paraphernalia, with the exception of
needles (yes/no, lifetime). The method of heroin use was
determined from the answers of the following question:
“What has been your main method for using heroin in the
past 6 months?” Heroin in Taiwan is sold using the tradi-
tional measuring unit of a half qian (1 qian Z 3.75 g). Pa-
tients were asked the amount of heroin (in half qian/d)
they used in the 2 weeks prior to the interview.
HIV infection among heroin users in Taiwan 675Blood samples were taken from the patients on entry to
treatment. The presence of HIV antibodies was tested by a
microparticle enzyme immunoassay (AxSYM HIV 1/2 gO;
Abbott Laboratories, Diagnostics Division, Abbott Park, IL)
and confirmed by western blot (NEW LAV BLOT 1; Bio-Rad,
France). The application of chemiluminescent immunoas-
says with the ARCHITECT i2000 system was used to detect
anti-hepatitis C virus (anti-HCV) and hepatitis B surface an-
tigen (HBsAg). These tests were performed at the Depart-
ment of Laboratory Medicine, Department of Health, Tai-
Chung Hospital, Taiwan.
We used the following self-administered questionnaires
for this study: the Chinese version of the Centre for
Epidemiologic Studies Depression Scale (CESD) [24,25] and
the Chinese version of the Severity of Dependence Scale
(SDS[Ch]) [26]. A positive correlation was found between
SDS[Ch] scores and DSM-IV criteria for heroin dependence
[27]; the family adaptation, partnership, growth, affection,
resolve scale (APGAR[Ch]) [28,29]; and the Chinese version
of the Barratt Impulsiveness Scale (BIS-11-CH) [30,31]. All
scales were validated in Taiwan, and total scores were used
for statistical analysis. Higher scores indicated more severe
conditions for all instruments. Risk perception regarding
HIV infection was assessed by the question “Do you have
HIV?” (the answer options: “yes”, “no”, or “not sure”).
Statistical analysis
We conducted a descriptive analysis to describe the socio-
demographic characteristics, heroin-related problems, and
HIV prevalence in the sample. Descriptive statistics, such as
means, standard deviations (SDs), and proportions, were
used when appropriate. The Chi-square test and t test were
used to assess the association of all variables, and all sig-
nificant factors were entered into a multivariate logistic
regression model (backward elimination) to identify signifi-
cant variables related to HIV infection after adjusting for the
potential effects of other variables. Kappa was used to
represent the agreement between self-reported HIV and
laboratory findings. A similar statistical procedure was per-
formed to establish significant variables related to needle
sharing. The variance inflation factor (VIF) was used to
detect multicollinearity in the regression model. Explana-
tory variables with a VIF of 5 indicates a multicollinearity
problem [32]. Differences were considered significant if
p < 0.05. An analysis was conducted using SPSS version 15.0
(SPSS Inc., Chicago, IL, USA).
Ethics
Our study was approved by the institutional review board of
the Tsaotun Psychiatric Center. All patients provided writ-
ten informed consent prior to participation.
Results
The total study sample comprised 781 heroin users with a
mean age of 36.1 years (SD Z 7.6); 710 (90.9%) were men
and 59.4% of all participants had received <9 years of ed-
ucation (mean 9.9, SD Z 2.0). Six patients were excluded
because of illiteracy or mental retardation. The mean agefor first heroin use was 26.2 years (SD Z 12.0). The most
frequently reported method of heroin administration (used
by 81.4% of the patients) was injection. Of the patients,
92.0% had criminal convictions related to substance-use
offences (possession/selling; nZ 2.3, SDZ 1.5) and 66.3%
related to nonsubstance use (n Z 1.2, SD Z 1.3).
Table 1 shows the sample characteristics related to HIV
serostatus. The prevalence of HIV infection among the
study population was 20.7%. The prevalence of HCV and
hepatitis B virus (HBV) was 90.1% and 66.2%, respectively.
In total, 154 men and eight women were diagnosed as HIV
seropositive. In the univariate analysis, HIV-positive pa-
tients were younger in age (34.2  6.9 years vs. 36.5  7.9
years; p Z 0.001) and younger in age for their first illegal
drug (22.1  6.2 years vs. 24.3  7.6 years; p < 0.001), had
more drug-related (2.7  1.6 vs. 2.2  1.5; p < 0.001) and
nondrug-related (1.6  1.5 vs. 1.1  1.2; p < 0.001) crim-
inal convictions, and were more likely to initiate heroin use
at a younger age (23.9  5.7 years vs. 26.8  13.1 years;
p Z 0.006) than HIV-negative patients. HIV-infected pa-
tients also tended to be more depressed (p Z 0.009). The
prevalence of HIV-positive users among the injecting heroin
users in this study group was 23.1%. Those who injected
heroin were more likely to be HIV positive (pZ 0.001). HIV-
positive patients were also more likely to test positive for
HCV infection (p < 0.001). Compared to HIV-negative her-
oin users, HIV-positive heroin users were more likely to be
men (p Z 0.039). HIV-positive patients reported more
sharing of needles (p < 0.001) and injection paraphernalia
(p < 0.001). The HIV subgroups did not differ significantly
regarding HBV. Factors such as family support, impulsivity,
education, detoxification frequency, and severity of
dependence were not significant in our study.
With respect to the degree of risk perception, 779 heroin
users responded regarding the risk perception of their HIV
status. Among them, 150 (19.3%) reported HIV infection,
553 (71.0%) reported HIV noninfection, and 76 (9.7%) were
unsure of their HIV status. A strong agreement existed be-
tween self-reported HIV serostatus and the results of the
laboratory analyses, with 88.8% of responders reporting
their condition correctly. Among the 150 HIV-infected her-
oin users identified by blood test, 91.9% reported their
condition correctly. We categorized the first answer as
infection (self-report) and the last two answers as no
infection (self-report) to calculate the kappa value with
laboratory results. The kappa was 0.94 [95% confidence
interval (CI), 0.91e0.97; pZ 0.005], showing a high level of
agreement [33]. We treated HIV serostatus as the gold
standard; the positive and negative predictive values were
0.987 and 0.979, respectively, in this study. The sensitivity
and specificity were 0.919 and 0.997, respectively. These
measurements also showed high levels of agreement be-
tween the self-reports and the HIV serostatus.
We performed a multivariate logistic regression analysis
with backward elimination to identify factors related to HIV
infection among heroin users. HIV infection was indepen-
dently associated with the age of initial heroin use [odds
ratio (OR), 0.95; 95% CI, 0.91e0.98; p Z 0.001], heroin
injection use (OR, 1.95; 95% CI, 1.01e3.49; p Z 0.025),
nondrug-related criminal convictions (OR, 1.95; 95% CI,
1.09e3.49; pZ 0.005), needle-sharing behaviors (OR, 2.11;
95% CI, 1.17e3.80; p Z 0.013), and sharing of injection
Table 1 Patient demographics and clinic characteristics of heroin users in Central Taiwan, 2006e2010.
Variable Total valid sample HIV p (t test)
Negative Positive
na Mean SD n Mean SD n Mean SD
Age (y) 781 36.1 7.6 619 36.5 7.9 162 34.2 6.9 0.001
Education (y) 781 9.9 2.0 619 9.9 2.1 162 9.7 1.9 0.193
Onset age of substance (y) 781 23.8 7.3 619 24.3 7.6 162 22.1 6.2 <0.001
Onset age of heroin use (y) 781 26.2 12.0 619 26.8 13.1 162 23.9 5.7 0.006
Dose of heroin (half qian/db) 780 5.0 5.1 618 4.9 5.2 162 5.3 5.0 0.459
Detoxification for heroin more than 2 wk (lifetime) 778 2.8 2.8 616 2.8 2.7 162 2.7 3.1 0.632
Severity of heroin dependence (SDS,c total score) 781 7.4 2.7 619 7.4 2.7 162 7.4 2.5 0.962
No. of criminal convictions (illegal substances) 779 2.3 1.5 618 2.2 1.5 161 2. 7 1.6 <0.001
No. of criminal convictions (nonsubstance causes) 777 1.2 1.3 617 1.1 1.2 160 1.6 1.5 <0.001
Impulsivity (Barrat Impulsivity Scalec) 725 72.5 8.7 569 72.2 7.8 156 73.5 11.3 0.104
Family support (APGARc) 781 5.7 4.3 619 5.6 4.3 162 6.1 4.3 0.161
Depression (CESD Scalec) 781 23.05 9.8 619 22.6 9.8 162 24.8 9.6 0.009
Variable Total valid sample size HIV p (Chi-square )
Negative Positive
n % n %
Sex Male 710 556 89.8 154 95.1 0.039
Female 71 63 10.2 8 4.9
Injection Yes 618 475 77.6 143 89.9 0.001
No 153 137 22.2 16 10.1
Needle sharing Yes 86 38 6.2 48 29.6 <0.001
No 693 579 93.8 114 70.4
Paraphernalia sharing Yes 148 70 11.3 78 48.1 <0.001
No 632 548 88.7 84 51.9
HCV Yes 704 542 88.0 162 100.0 <0.001
No 74 74 12.0 0 0.0
HBV Yes 517 411 66.2 106 65.4 0.777
No 262 206 33.4 56 34.6
APGAR Z adaptation, partnership, growth, affection, resolve score; CESD Z Centre for Epidemiologic Studies Depression;
HCV Z hepatitis C virus; HBV Z hepatitis B virus; SD Z standard deviation; SDS Z Severity of Dependence Scale.
a Total number of observations do not sum up to 781 for all variables due to missing values.
b 1 qian Z 3.75 g (number of half qians of heroin used per day).
c Chinese versions.
Table 2 Multivariate logistic regression analysis for
human immunodeficiency virus (HIV) infection among 781
heroin users in Central Taiwan, 2006e2010.
Variables Odds ratio p Variance
inflation
factor
Estimate (95% CI)
Onset age of
heroin use (y)
0.95 0.91e0.98 0.001 1.04
Vessel or muscle
injection of heroin
1.95 1.01e3.49 0.025 1.04
Criminal convictions
(nonsubstance
causes)
1.95 1.09e3.49 0.005 1.01
Needle sharing 2.11 1.17e3.80 0.013 1.45
Paraphernalia
sharing
5.17 3.18e8.41 0.000 1.45
CI Z confidence interval.
676 T.-Y. Lin et al.paraphernalia (OR, 5.17; 95% CI, 3.18e8.41; p < 0.001;
Table 2). The VIFs of explanatory variables of <5 indicated
limited multicollinearity in the previous final regression
model (Table 2). All models in the model selection process
also included variables with VIFs of <5.
We performed a similar analysis to identify factors
related to needle sharing among heroin users. Needle
sharing was independently associated with the severity
of heroin dependence (OR, 1.17; 95% CI, 1.05e1.32;
p Z 0.006), family support (OR, 0.91; 95% CI, 0.85e0.98;
pZ 0.010), sharing injection paraphernalia (OR, 20.59; 95%
CI, 10.78e39.32; p < 0.001), and HIV infection (OR, 2.75;
95% CI, 1.47e5.15; pZ 0.002). The VIF also showed limited
multicollinearity in the model selection process (Table 3).
Discussion
The results showed a high rate of HIV infection (20.7%)
among the heroin users seeking treatment at the MMT
program. The prevalence was much higher than that of the
Table 3 Multivariate logistic regression analysis for nee-
dle sharing among 781 heroin users in Central Taiwan,
2006e2010.
Variables Odds ratio p Variance
inflation
factor
Estimate (95% CI)
Severity of heroin
dependence
(SDS, total
score)
1.17 1.05e1.32 0.006 1.03
Family support
(APGAR)
0.91 0.85e0.98 0.01 1.01
Paraphernalia
sharing
20.59 10.78e39.32 <0.001 1.19
HIV infection
(serostatus)
2.75 1.47e5.15 0.002 1.17
APGAR Z adaptation, partnership, growth, affection, resolve
score; CIZ Confidence interval; SDSZ Severity of Dependence
Scale.
HIV infection among heroin users in Taiwan 677general population in Taiwan (0.082% in 2009) [4]. The HIV
rate among those who used heroin by injection was 23%.
Among the general population in Taiwan, the prevalence of
chronic HBV carriers is estimated to be 15e20% and the
prevalence of HCV infection 3e4% [34]. Our findings show a
high prevalence of HBV (66.2%) and HCV (90.1%) infection
among heroin users. The high prevalence of HIV infection
among this study population should be viewed in the
context of the findings from other Asian countries. The HIV
prevalence among injecting heroin users is as low as 2.6% in
Australia, and as high as 28% in Indonesia [2] or 52% in
Thailand [2]. The rate in other countries ranges from 1% in
New Mexico, USA [35]; 20.4% in Vancouver, Canada [13,36];
to 31.7% in Madrid and Barcelona, Spain [13]. In Taiwan,
Chen et al. [7] reported a higher HIV-infection frequency
(38%) than that of our study, possibly because their patients
belonged to a higher-risk population (male incarcerated
IDUs).
Our results also indicated that HIV-positive heroin users
were more likely to be those who injected heroin, and
shared needles and other injection paraphernalia.
A previous study in Taiwan also found that a shift in
heroin administration from smoking to injection, and
increased needle-sharing behaviors further exacerbated
the HIV epidemic [7]. HIV prevalence among drug addicts
has reduced by half within the past 4 years. However,
among the HIV-infected population, the proportion of drug
users remains approximately one-third [4]. Our study re-
sults indicated that drug injection is still a crucial factor
associated with HIV infection in Taiwan.
Our results are consistent with the results of several
other studies regarding the strong association between
sharing needles and/or injection paraphernalia and HIV
infection [11]. Needle-sharing behaviors are typically
associated with outbreaks of HIV/AIDS in Thailand, India,
Malaysia, Burma, China, and Vietnam [31]. The prevalence
of injecting and sharing injection equipment becomes
lower in patients admitted to addiction treatment service
programs [37]. The proportion of drug users remains highamong the HIV-infected population [4]. Our findings suggest
that sharing needles/injections and/or paraphernalia
remain important factors relating to HIV infection. Coun-
seling for IDUs should emphasize the risks of indirect
sharing and use of injection paraphernalia [13].
Heroin users in our study group first used heroin at a
mean age of 23.9 years (SD  5.7). Patients whose initial
use of heroin occurred at a younger age were more likely to
test positive for HIV infection. This finding is consistent
with the findings of other studies conducted in India [11],
indicating that earlier heroin use was related to injecting
heroin at an earlier age [38], and younger IDUs were re-
ported to borrow current injection equipment more often
than older IDUs [39]. Greater attention should be focused
on the needs of younger heroin users to help delay or
prevent the onset of drug injecting [39]. HIV-positive her-
oin users were more likely to have nondrug criminal con-
victions in this study group. Although other studies have
examined drug-related criminal convictions and HIV
infection [18,23], none has investigated nondrug-related
criminal convictions among heroin users and HIV infec-
tion. Our study is the first in Asia to examine the percep-
tions of HIV status among heroin users, and our results
show that more than 90% of HIV-positive patients know
their status. Because similar studies on heroin users do not
exist, a comparison was not feasible. Compared with the
findings from other populations, our findings are similar to
previous reports on the general population in Malawi (71%)
[22] and on men who have sex with men in Brazil
(kappa Z 0.88) [40], but contrary to those on the general
population of Nigerians [41]. The high-risk perception may
be because of good public health education in Taiwan. We
did not have information on the influence of their risk
perception on their own heroin-related behaviors, such as
engaging in fewer unprotected sexual acts, and sharing
needles or paraphernalia. Further research is necessary to
explore this issue.
Our study findings should be interpreted according to
certain study design limitations. The cross-sectional study
design is limited to determining the causality relationship
among variables; the measurement of psychosocial factors
is based on self-reported behaviors. The potential for social
desirability bias exists, such as underestimating impulsivity
characteristics. The sample was not selected randomly and
was recruited from a psychiatric center in Central Taiwan;
therefore, our results might not be applicable to other
settings. These heroin users may be a highly select group
with greater dependence severity and higher risk behav-
iors. The prevalence of HIV infection may be overestimated
among this population. The information regarding sexual
behavior is insufficient; in certain countries such as China,
heterosexual transmission has become the dominant mode
of HIV transmission [42].
Our study also has certain strengths. It is the first study
to examine risk perceptions of HIV status among heroin
users in Asia. Of the studies related to heroin use and HIV
infection in Taiwan [7,43], our study contains the largest
group sample and is the only study investigating the popu-
lation of both injecting and noninjecting heroin users. We
explored psychosocial and heroin-related behaviors
comprehensively in this study to provide more complete
information on the current trends of HIV infection among
678 T.-Y. Lin et al.heroin users in Taiwan. Our study is beneficial for advancing
further the effectiveness of current treatment programs,
including maintenance-related programs.
In conclusion, we identified the current factors associ-
ated with HIV infection among heroin users in Taiwan. Our
results are helpful for formulating and modifying preven-
tion programs in the country. Prevention programs should
emphasize on disseminating knowledge about drug addic-
tion and HIV infection in adults and younger groups prior to
people using illegal drugs. Although a harm-reduction pro-
gram has been pursued for approximately 4 years in
Taiwan, needle- and injection paraphernalia-sharing be-
haviors are strongly associated with HIV infection among
heroin users in the country. Educational programs should
apply greater emphasis on perceiving the risks of drug-use
behavioral patterns to increase the motivation for behav-
ioral change. Providing specific advice on avoiding alcohol
or heavy drinking is critical because of the high rate of viral
hepatitis among HIV-infected patients. Establishing a close
liaison between MMT services and medical services is also
vital to provide antiretroviral or liver disease treatments.Acknowledgments
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